Health

Navigating VAP Guidelines: Essential Strategies for Infection Prevention and Control

by
Ventilator-associated pneumonia

Ventilator-associated pneumonia (VAP) represents a crucial concern in intensive care units (ICUs) worldwide, posing substantial threats to patient safety. It’s not only associated with increased morbidity and mortality, but it also significantly inflates healthcare costs and prolongs hospital stays. This article aims to illuminate essential strategies for navigating VAP guidelines, presenting an actionable roadmap for … Read more

Empowering Physicians and Enhancing Patient Respiratory Health

by
Empowering Physicians and Enhancing Patient Respiratory Health

With a rich history spanning over three decades, the National Association for Medical Direction of Respiratory Care (NAMDRC) continues to be a pioneering national organization comprised of dedicated physicians. Our mission remains steadfast: to educate our esteemed members and tackle the regulatory, legislative, and payment challenges that impact the delivery of exceptional healthcare to individuals … Read more

FDA Removes Boxed Warning from Long-Acting Beta Agonists (LABAs) and Inhaled Corticosteroids (ICS)

by
FDA Removes Boxed Warning - Stay Informed 1

On December 20, 2017 the FDA removed its most prominent warning, the Boxed Warning, about asthma-related death from the drug labels of medicines that contain both an ICS and LABA. These include Advair Diskus, Advair HFA, Airduo Respiclick, Breo Ellipta, Dulera, and Symbicort. The controversy surrounding LABAs has persisted since salmeterol was originally approved by the FDA … Read more